| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/30/2000 | WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor |
| 03/30/2000 | WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 03/30/2000 | DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations |
| 03/30/2000 | DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments |
| 03/30/2000 | DE19837928A1 Treating summer eczema or malanders, especially in horses, using topical herbal composition derived from Equisetum plants, giving rapid cure of itching and chafing |
| 03/30/2000 | CA2344919A1 Active enantiomer of rar.gamma.-specific agonist |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/30/2000 | CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | CA2342957A1 Regulatory protein from human keratinocytes |
| 03/30/2000 | CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988374A1 Hydrophilic composition containing protease produced by vibrio |
| 03/29/2000 | EP0988319A1 Human l105 proteins and polynucleotides encoding same |
| 03/29/2000 | EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 03/29/2000 | EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines |
| 03/29/2000 | EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties |
| 03/29/2000 | EP0988044A1 Centipeda plant extract |
| 03/29/2000 | EP0988040A1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| 03/29/2000 | EP0988033A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 03/29/2000 | EP0988029A1 Device and methods for wound treatment |
| 03/29/2000 | EP0987942A1 Pharmaceutical composition and methods for using it |
| 03/29/2000 | EP0801554A4 Formulations and methods for reducing skin irritation |
| 03/29/2000 | EP0778731B1 Ionene polymers containing biologically-active anions |
| 03/29/2000 | EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 03/29/2000 | CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor |
| 03/29/2000 | CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF |
| 03/29/2000 | CN1248916A Use of FXR, PPAR 'alpha' and LXR 'alpha' activators to restore barrier function, promote epidermal differentiation and inhibit proliferation |
| 03/29/2000 | CN1248910A Bar composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 03/29/2000 | CN1248909A Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 03/29/2000 | CN1248907A Composition for enhancing skin or hair |
| 03/29/2000 | CN1248466A Yuchuang oinment for treating sore |
| 03/29/2000 | CN1248460A Medicine for treating burn (scald) and preparation process |
| 03/29/2000 | CN1248459A Medicine for weight-reducing and beautifying |
| 03/29/2000 | CN1248456A Health care foods for acne-removing and beautifying and preparation thereof |
| 03/29/2000 | CN1050844C Protein kinase C inhibitors |
| 03/29/2000 | CN1050840C 咪唑脂氧合酶抑制剂 Imidazole lipoxygenase inhibitors |
| 03/29/2000 | CN1050761C Oral administration liquid for curing acne and preparation process thereof |
| 03/29/2000 | CN1050760C Traditional Chinese medicine for treating soft tissue injury and dermatosis |
| 03/29/2000 | CN1050753C Wound healing preparation |
| 03/29/2000 | CA2281418A1 Use of a silicone gum to stabilize ascorbic acid and novel compositions containing these components |
| 03/28/2000 | US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 03/28/2000 | US6043365 Reacting biaryl or carbocyclic or heterocyclic isopropyl nitrile derivative with a lower alkyl ester of formic acid, condensing the intermediate formed with an aminoalkyl ester to obtain intermediate, cyclizing and condensing |
| 03/28/2000 | US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
| 03/28/2000 | US6043239 Heterocyclic compounds |
| 03/28/2000 | US6043202 Shampoo compositions and oil compositions and methods for treatment of cradle cap |
| 03/28/2000 | US6042845 Anti fungal treatment of nails |
| 03/28/2000 | US6042840 Component of a skin care agent |
| 03/28/2000 | US6042620 p-diaminobenzene derivative compounds and dye compositions containing same |
| 03/28/2000 | CA2177968C Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| 03/28/2000 | CA2063862C Topical preparation containing a suspension of solid lipid particles |
| 03/26/2000 | CA2403011A1 Apparatus for electrical moxibustion using the extract |
| 03/26/2000 | CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract |
| 03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
| 03/23/2000 | WO2000015793A2 Human gpcr proteins |
| 03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/23/2000 | WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 03/23/2000 | WO2000015775A1 Rnase p polypeptides |
| 03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
| 03/23/2000 | WO2000015769A1 Topa |
| 03/23/2000 | WO2000015614A1 Novel compounds |
| 03/23/2000 | WO2000015248A2 Growth factor-containing composition for healing tissue damage |
| 03/23/2000 | WO2000015208A2 New use of immunosupressants for mmp-mediated diseases |
| 03/23/2000 | WO2000015188A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/23/2000 | WO2000015179A2 Cosmetic composition |
| 03/23/2000 | WO2000015167A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 03/23/2000 | WO1999066948A3 Use of a dipeptide for stimulating repair processes |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/23/2000 | DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease |
| 03/23/2000 | DE19838377A1 Verfahren und Vorrichtung zur Extraktherstellung aus biologischem Material, dadurch hergestellte Extrakte und deren Verwendung Method and apparatus for manufacture of extracts from biological material, characterized Extracts prepared and their use |
| 03/23/2000 | CA2343578A1 Human serine/threonine protein kinases |
| 03/23/2000 | CA2343223A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 03/23/2000 | CA2342833A1 Human gpcr proteins |
| 03/23/2000 | CA2342301A1 Human cell junction pdz protein |
| 03/23/2000 | CA2341440A1 Novel compounds |
| 03/23/2000 | CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 03/23/2000 | CA2281197A1 Active component delivery system comprising a coating structure on which is found a salicylic acid derivative-based composition, and its uses |
| 03/22/2000 | EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit |
| 03/22/2000 | EP0987552A2 Diarylsulfonylurea binding proteins |
| 03/22/2000 | EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/22/2000 | EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid |
| 03/22/2000 | EP0987016A1 Antiwrinkle composition containing a combination of tensor polymers from synthetic and/or natural origin and dendritic polyesters |
| 03/22/2000 | EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones |
| 03/22/2000 | EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 03/22/2000 | EP0986537A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 03/22/2000 | EP0986530A1 Indane compounds and their pharmaceutical use |
| 03/22/2000 | EP0986408A1 New medicaments based on polymers composed of methacrylamide-modified gelatin |